Key result
Thrombocytopenic states are linked to ~264% higher serum thrombopoietin and increased platelet cMpl expression versus controls.
Why the study?
The relationship between thrombopoietin and its receptor cMpl in thrombocytopenic conditions has not been entirely clarified.
Observational (n=75)
No
Thrombocytopenic states are associated with increased platelet cMpl expression and generally higher TPO levels compared to healthy controls.
Answers are grounded in this paper and cite their sources.
No immediate change to thrombocytopenia management; leaves open TPO/cMpl axis as therapeutic target in ITP and MDS.
The relationship between thrombopoietin (TPO) and its receptor cMpl in thrombocytopenic conditions has not been entirely clarified. To elucidate this interplay may expand the spectrum of indications of TPO mimetics. In this study we have explored the relationship between TPO and cMpl in platelets and megakaryocytes of 43 patients with thrombocytopenia due to idiopathic thrombocytopenic purpura (ITP), bone marrow hypoplasia, myelodysplastic syndromes (MDS), and familial thrombocytopenia. Data were compared to cMpl and TPO in patients with a normal platelet count and in patients with thrombocytosis due to essential thrombocythemia (ET). All but familial patients showed higher TPO compared to controls. All thrombocytopenic states were invariably associated with increased expression of platelet cMPL compared to healthy controls. ET patients showed normal TPO and a trend toward a reduced cMpl expression. Immunofluorescence of bone marrow sections from patients with ITP and MDS failed to show a peculiar pattern compared to controls. Multiple mechanisms regulate TPO and cMpl in thrombocytopenic conditions.
No takes yet. Share an insight, caveat, or question.
Vianello et al. (2014) conducted an observational in Thrombocytopenia of different etiologies (n=75). Thrombocytopenic conditions (e.g., ITP, MDS, bone marrow hypoplasia) vs. Healthy controls was evaluated on Serum thrombopoietin (TPO) levels (pg/mL) in ITP patients vs controls (p=<0.001). Thrombocytopenic states including ITP, MDS, and bone marrow hypoplasia were associated with significantly increased serum thrombopoietin levels and platelet cMpl expression compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: